news alert

Keep Your Eyes on This Stock Alert: Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) spotted trading -24.07% off 52-week high price. On the other end, the stock has been noted 48.96% away from the low price over the last 52-weeks. The stock changed 2.42% to recent value of $96.41. The stock transacted 848069 shares during most recent day however it has an average volume of 651.55K shares. The company has 90.62M of outstanding shares and 90.38M shares were floated in the market.  

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced the appointment of Leslie V. Norwalk to its Board of Directors. Ms. Norwalk formerly served as Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) under the George W. Bush administration and is currently Strategic Counsel to healthcare companies at Epstein Becker Green, EBG Advisors and National Health Advisors.

“We are excited to welcome Leslie Norwalk to the Neurocrine Biosciences Board of Directors,” said William H. Rastetter, Chairman of the Board of Neurocrine Biosciences. “Leslie’s tenure as an administrator at the Centers for Medicare & Medicaid Services, coupled with her extensive background in healthcare policy and regulatory matters will be invaluable as Neurocrine Biosciences continues to grow and evolve as a commercial-stage biopharmaceutical company focused on developing life-changing treatments for people with neurological, endocrine and psychiatric disorders.”

Ms. Norwalk serves as a director of NuVasive, Endologix, Providence Service Corporation, Magellan Health, and Arvinas, as well as several privately-held healthcare companies. She also serves as a healthcare, regulatory and policy advisor to several private equity firms. Ms. Norwalk began her career in the public sector as a special assistant in The White House Office of Presidential Personnel under the first Bush administration, following which, she practiced law at the Washington, D.C. office of Epstein Becker Green. While at the CMS, Ms. Norwalk served as Deputy Administrator, and Counselor and Policy Advisor, before assuming the role of Acting Administrator. Ms. Norwalk holds a Juris Doctorate from the George Mason University School of Law and a Bachelor of Arts degree in economics and international relations from Wellesley College.

 Its earnings per share (EPS) expected to touch remained 113.70% for this year . NBIX has a gross margin of 99.00% and an operating margin of 1.60% while its profit margin remained 3.00% for the last 12 months. 

 According to the most recent quarter its current ratio was 7.4 that represents company’s ability to meet its current financial obligations. The price moved ahead of -1.13% from the mean of 20 days, 3.71% from mean of 50 days SMA and performed 13.60% from mean of 200 days price. Company’s performance for the week was -2.62%, 2.15% for month and YTD performance remained 35.01%.

John Gonzalez covers business and finance news. He is the only person we trust to provide breaking news in the finance category. Having already completed an Associates Degree in Psychology, John Gonzalez is now finishing his Bachelor’s degree in Communications. In preparation for working in the advertisement sector, John is writing financial content and analysis. On a daily basis, he works on articles regarding the following topics: business, top trends, technology, and politics.

Address: 7302 Benton Street, Arvada, CO 80003, USA


Zip Code: 80003

Phone Number: 303-420-7222

Leave a Reply

Your email address will not be published. Required fields are marked *